FDA Voices
Insights from FDA leadership and experts into the agency's work to protect public health.
For FDA Voices older than 2023, please view the archived page.
Sub-Topic Paragraphs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
An America First Approach to Medical Innovation
The FDA’s new Expedited IND Pilot will cut unnecessary delays in early-stage clinical research without compromising patient safety
Good Clinical Practices Are Not Optional: The FDA’s Commitment to Human Subject Protections and Gold Standard Science in an Era of Global Clinical Research
The FDA’s position is clear: GCP is not bureaucratic formality. It is the scientific and ethical foundation on which our regulatory decisions rest.
Some table information
| Published Date | Image | Title | Detailed Description | Regulated Products | Health Topics (Hidden) |
|---|